Issues in Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents: Kill Curves versus MIC
Open Access
- 1 February 2004
- journal article
- review article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 48 (2), 369-377
- https://doi.org/10.1128/aac.48.2.369-377.2004
Abstract
No abstract availableThis publication has 111 references indexed in Scilit:
- Basis of Anti-Infective TherapyClinical Pharmacokinetics, 1999
- An Evaluation of the Integration of Pharmacokinetic and Pharmacodynamic Principles in Clinical Drug DevelopmentClinical Pharmacokinetics, 1997
- Antimicrobial resistance issues of the futureDiagnostic Microbiology and Infectious Disease, 1996
- Pharmacokinetic‐pharmacodynamic model for spiramycin in staphylococcal mastitisJournal of Veterinary Pharmacology and Therapeutics, 1996
- Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USAEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995
- Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporinsDiagnostic Microbiology and Infectious Disease, 1995
- The Importance of Pharmacokinetic/Pharmacodynamic Surrogate Markers to OutcomeClinical Pharmacokinetics, 1995
- Microbial pharmacodynamics of piperacillin in neutropenic mice of systematic infection due toPseudomonas aeruginosaJournal of Pharmacokinetics and Biopharmaceutics, 1988
- Time course of the pharmacological response to beta-lactam antibiotics in vitro and in vivoEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- Pharmacodynamics of Chemotherapeutic Effects: Dose-Time-Response Relationships for Phase-Nonspecific AgentsJournal of Pharmaceutical Sciences, 1971